Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pancreatic cancer
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-6 of 6 for your search:
Start Over
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: NLG0505, NCI-2013-01044, 1210-1195, NCT01836432
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Combination Chemotherapy Followed by Ipilimumab and Vaccine Therapy in Treating Patients with Metastatic Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J13108, NCI-2013-02238, FD-R-004819-01, NA_00086350, 9478, NCT01896869
Vaccine Therapy and Cyclophosphamide with or without Nivolumab in Treating Patients with Previously Treated Metastatic Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J14113, NCI-2015-00233, ADU-CL-06, CA209-248, NCT02243371
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI-DSP7888-101, NCI-2015-01357, NCT02498665
Start Over